Before
the end of 2018, health food imported through CBEC needn’t get registration or filing
approval. Therefore, in recent years, many foreign health food brands have
entered the Chinese market through CBEC platforms. Quite a lot of them have accumulated great reputation and popularity in China, such as Swisse, GNC and so
on.
For
Chinese-funded enterprises, the acquisition of these well-known overseas health
food enterprises with high consumer awareness and popularity is undoubtedly a
short-cut for realizing enterprise expansion, opening its own brand awareness,
and quickly seizing the domestic health food market. Therefore, driven by
multiple benefits, Chinese-funded enterprises have frequently purchased
“foreign health food brands” in recent years. In 2016, Swisse was incorporated
into Health & Happiness Group. And in February 2018, Harbin Pharmaceutical
Group bought 40% shares of GNC, spending 300 million USD.
Table 1 Cases of Chinese-funded
Enterprises Acquiring Overseas Health Food Enterprises (Incomplete Statistics)
Chinese
enterprise/brand
Time
Foreign
enterprise /brand
Holding
shares
Amount
Health & Happiness Group
2015.9
Australia: SWISSE
83%
1.386 billion AUD
1.697 billion AUD
2016.12
17%
0.311 billion AUD
Kingdomway
2015.1
America: Doctor’s Best Holdings
51%
35 million USD
2015.6
America: Vitatech
Undisclosed
0.595 billion RMB
2017.2
America: Labrada
30%
8.1 million USD
2017.6
Singapore: VITAKIDS
PTE.LTD.
95%
17.48 million RMB
Singapore: PINK
OF HEALTH PTE.LTD.
95%
2018.5
America: ZIPFIZZ CORPORATION
100%
80 million USD
Aland
2010
America: Inverness Medical Company Nutrition
Department (IVC)
100%
63.4 million USD
2014.6
America: Adam Nutrition
Undisclosed
Undisclosed
2016.3
Netherlands: Bloem Health Products B.V.
Undisclosed
Undisclosed
2016.6
America: Nutrition business of Perrigo
100%
Undisclosed
2016.12
Britain: Brunel Healthcare Manufacturing Limited
100%
Undisclosed
Britain: Biocare Limited
100%
Undisclosed
Sinolife United
2014.11
New Zealand: Good Health
60%
23.27 million NZD
Fosun
40%
By-Health
2016.3
Establish a joint venture with NBTY(America) in Hong
Kong, obtain the permanent rights to operate Nature's Bounty and Met-RX and
use the trademarks of them in the Chinese market
60%
80~120 million RMB
Shanghai Pharma
2016.8
Australia: Vitaco
60%
1.58 billion RMB
Primavera Capital Group
40%
Ausnutria
2016.8
Australia: Nutrition Care
100%
0.16 billion RMB
New Hope Group
2016.8
Australia: Australian NaturalCare (ANC)
100%
Undisclosed
Xiwang Food
2016.9
Canada: Kerr Investment Holdings
80%
0.73 billion USD
Primavera Capital Group
20%
Sirio Pharma
2016.12
Germany: Ayanda
100%
Undisclosed
CDH Fund
2017.3
New Zealand: Better Health
80%
Undisclosed
HGGC LL
2017.5
America: Nutraceutical International Corp
Undisclosed
0.446 billion USD
Firmus
2017.12
America: Vitamin World
Undisclosed
28 million USD
Harbin Pharmaceutical Group
2018.2
America: GNC
40%
0.3 billion USD
Most brands already have strategic plans in the
Chinese market, some have applied registration and filing with former CFDA,
some have got the filing certificates. The details are presented in Section
2: How Many Health Food are Registered in China of which is
issued by CIRS. If you would like to get the to get more
complete information pertaining to Chinese health food, please click here to order it.
If you have any needs or questions, please contact us at service@cirs-group.com.
We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.